AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20586601 — intervention group
Group type: COMPARATOR
Intervention: Standing at sea level for 3 min
Number of subjects: 10
Study 20586601 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing at high altitude (5050 m) for 3 min
Number of subjects: 10
Study 20586601 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial responses to standing at HA
Number of subjects: 10
Study 20586601 — intervention group
Group type: COMPARATOR
Intervention: Middle cerebral artery blood velocity (MCAv) at 3 min
Number of subjects: 10
Study 18236139 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg) three times per day for 5 days
Number of subjects: 8
Study 18236139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 15867662 — intervention group
Group type: EXPERIMENTAL
Intervention: Floseal
Number of subjects: 70
Study 15867662 — intervention group
Group type: COMPARATOR
Intervention: Nasal packing
Number of subjects: 70
Study 14658947 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 18
Study 14658947 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 18
Study 14658947 — intervention group
Group type: COMPARATOR
Intervention: Various NSAIDs (including aspirin and sulindac)
Number of subjects: 18
Study 10783359 — intervention group
Group type: EXPERIMENTAL
Intervention: CDB-2914 (10 mg)
Number of subjects: 44
Study 10783359 — intervention group
Group type: EXPERIMENTAL
Intervention: CDB-2914 (50 mg)
Number of subjects: 44
Study 10783359 — intervention group
Group type: EXPERIMENTAL
Intervention: CDB-2914 (100 mg)
Number of subjects: 44
Study 10783359 — intervention group
Group type: EXPERIMENTAL
Intervention: CDB-2914 (all doses)
Number of subjects: 44
Study 10783359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 9254992 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydration
Number of subjects: 65
Study 9254992 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide diuresis
Number of subjects: 65
Study 9254992 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hydration
Number of subjects: 65
Study 9254992 — intervention group
Group type: COMPARATOR
Intervention: Mannitol
Number of subjects: 65
Study 1387929 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 187
Study 1387929 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 187
Study 6696210 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula suspension (oral challenge)
Number of subjects: 6
Study 31227014 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily for 90 days
Number of subjects: 189
Study 31227014 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 189
Study 28948979 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (2 ng/kg)
Number of subjects: 29
Study 28948979 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 29
Study 26944475 — intervention group
Group type: EXPERIMENTAL
Intervention: HOXA-positive early thymic precursor
Number of subjects: 209
Study 26944475 — intervention group
Group type: COMPARATOR
Intervention: HOXA-negative early thymic precursor
Number of subjects: 209
Study 26944475 — intervention group
Group type: EXPERIMENTAL
Intervention: HOXA-positive cases with chemoresistance
Number of subjects: 209
Study 26944475 — intervention group
Group type: EXPERIMENTAL
Intervention: HOXA-positive cases with minimal residual disease positivity
Number of subjects: 209
Study 26944475 — intervention group
Group type: EXPERIMENTAL
Intervention: HOXA positivity
Number of subjects: 209
Study 24378958 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg doxycycline daily for 4 months
Number of subjects: 31
Study 24378958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 22157087 — intervention group
Group type: EXPERIMENTAL
Intervention: Mustard preparation (20 g, 25 mg total ITC) daily for 4 days
Number of subjects: 14
Study 20400377 — intervention group
Group type: EXPERIMENTAL
Intervention: NGX-4010 (8% w/w capsaicin patch), applied for 60 minutes
Number of subjects: 0
Study 18568273 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP approximately T + hepatitis B vaccine at 0, 6, and 14 weeks
Number of subjects: 424
Study 18568273 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP approximately T + hepatitis B vaccine at 6, 10, and 14 weeks
Number of subjects: 424
Study 18568273 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP approximately T
Number of subjects: 424
Study 18568273 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP approximately T + hepatitis B vaccine
Number of subjects: 424
Study 16053121 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath therapy
Number of subjects: 36
Study 16053121 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 36
Study 12358164 — intervention group
Group type: EXPERIMENTAL
Intervention: Overdrive atrial pacing before cardioversion
Number of subjects: 15
Study 12358164 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable atrial capture
Number of subjects: 15
Study 12358164 — intervention group
Group type: COMPARATOR
Intervention: No atrial capture
Number of subjects: 15
Study 10562843 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 0
Study 10562843 — intervention group
Group type: COMPARATOR
Intervention: Blinded control
Number of subjects: 0
Study 10562843 — intervention group
Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 0
Study 10562843 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical analysis
Number of subjects: 0
Study 10562843 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent
Number of subjects: 0
Study 10562843 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional equipoise
Number of subjects: 0
Study 10562843 — intervention group
Group type: EXPERIMENTAL
Intervention: Utilitarian philosophy
Number of subjects: 0
Study 10562843 — intervention group
Group type: EXPERIMENTAL
Intervention: Managed care
Number of subjects: 0
Study 8983643 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicutaneous (EP) test
Number of subjects: 45
Study 8983643 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermic (ID) test
Number of subjects: 45
Study 8983643 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EP and ID tests
Number of subjects: 45
Study 1856301 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention
Number of subjects: 100
Study 1856301 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 100
Study 1856301 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention control intervention
Number of subjects: 100
Study 1856301 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 7109988 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote mental healing treatment by healers
Number of subjects: 96
Study 7109988 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal medical treatment)
Number of subjects: 96
Study 7109988 — intervention group
Group type: EXPERIMENTAL
Intervention: Healers' treatment
Number of subjects: 96
Study 27626240 — intervention group
Group type: EXPERIMENTAL
Intervention: Single layer unlocked suturing
Number of subjects: 435
Study 27626240 — intervention group
Group type: EXPERIMENTAL
Intervention: Single layer locked suturing
Number of subjects: 435
Study 27626240 — intervention group
Group type: EXPERIMENTAL
Intervention: Double layer suturing
Number of subjects: 435
Study 27626240 — intervention group
Group type: COMPARATOR
Intervention: Double layer closure
Number of subjects: 435
Study 27626240 — intervention group
Group type: COMPARATOR
Intervention: Single layer unlocked suture
Number of subjects: 435
Study 27460638 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with anthracyclines
Number of subjects: 1066
Study 27460638 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy without anthracyclines
Number of subjects: 1066
Study 23928155 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical screws
Number of subjects: 80
Study 23928155 — intervention group
Group type: COMPARATOR
Intervention: Miniplates
Number of subjects: 80
Study 23778382 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day amisulpride plus 800 mg/day sulpiride
Number of subjects: 92
Study 23778382 — intervention group
Group type: COMPARATOR
Intervention: 800 mg/day amisulpride
Number of subjects: 92
Study 20573482 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 10
Study 20573482 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study 20573482 — intervention group
Group type: EXPERIMENTAL
Intervention: All randomized participants
Number of subjects: 10
Study 20573482 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-regression
Number of subjects: 10
Study 17981885 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.55 g/kg/day protein diet
Number of subjects: 392
Study 17981885 — intervention group
Group type: COMPARATOR
Intervention: 0.8 g/kg/day protein diet
Number of subjects: 392
Study 15698702 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling
Number of subjects: 0
Study 15698702 — intervention group
Group type: EXPERIMENTAL
Intervention: Heating
Number of subjects: 0
Study 12854480 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon-fiber resistive-heating blanket
Number of subjects: 24
Study 12854480 — intervention group
Group type: COMPARATOR
Intervention: Lower-body forced-air system
Number of subjects: 24
Study 12854480 — intervention group
Group type: COMPARATOR
Intervention: Circulating water mattress
Number of subjects: 24
Study 10564629 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person counseling
Number of subjects: 808
Study 10564629 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone plus letter
Number of subjects: 808
Study 10564629 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person plus letter
Number of subjects: 808
Study 10564629 — intervention group
Group type: COMPARATOR
Intervention: Physician letter
Number of subjects: 808
Study 10564629 — intervention group
Group type: COMPARATOR
Intervention: Telephone alone
Number of subjects: 808
Study 10564629 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-plus-letter
Number of subjects: 808
Study 8729588 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg/day combined with bezafibrate 400 mg/day
Number of subjects: 0
Study 8729588 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 10 mg combined with cholestyramine 8 g/day
Number of subjects: 0
Study 8729588 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg combined with cholestyramine 8 g/day
Number of subjects: 0
Study 8729588 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 10 mg combined with cholestyramine 8 g/day after 8 weeks
Number of subjects: 0
Study 8729588 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg combined with cholestyramine 8 g/day after 8 weeks
Number of subjects: 0
Study 8729588 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin 20 mg
Number of subjects: 0
Study 8729588 — intervention group
Group type: COMPARATOR
Intervention: Niacin monotherapy
Number of subjects: 0
Study 8729588 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg combined with niacin (3 g/day)
Number of subjects: 0
Study 1678271 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 mg transdermal patch
Number of subjects: 12
Study 1678271 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 to 21 mg transdermal patches
Number of subjects: 12
Study 1678271 — intervention group
Group type: EXPERIMENTAL
Intervention: transdermal patches
Number of subjects: 12
Study 6137977 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (group A)
Number of subjects: 50
Study 6137977 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium bromide (group B)
Number of subjects: 50
Study 6137977 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (group C)
Number of subjects: 50
Study 6137977 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium bromide (group D)
Number of subjects: 50
Study 30580464 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information
Number of subjects: 30
Study 29873739 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 100
Study 29873739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 25582578 — intervention group
Group type: EXPERIMENTAL
Intervention: Diosmectite group (diosmectite and mesalazine)
Number of subjects: 120
Study 24223806 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based brief alcohol intervention
Number of subjects: 907
Study 24223806 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 907
Study 21999125 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication
Number of subjects: 0
Study 21999125 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 20035586 — intervention group
Group type: EXPERIMENTAL
Intervention: Equasym XL/Metadate CD
Number of subjects: 184
Study 20035586 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerta
Number of subjects: 184
Study 20035586 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 184
Study 17242633 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation (group A, n = 22)
Number of subjects: 44
Study 17242633 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐estradiol at a dose of 50 mug/day and nomegestrol at a dose of 5 mg/day (group B, n = 22)
Number of subjects: 44
Study 17242633 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 14739793 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA)
Number of subjects: 36
Study 14739793 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 36
Study 14739793 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 36
Study 14739793 — intervention group
Group type: EXPERIMENTAL
Intervention: EACA and Aprotinin
Number of subjects: 36
Study 11159619 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptococcal spray
Number of subjects: 130
Study 11159619 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 130
Study 9627950 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaprozin for 6 weeks
Number of subjects: 80
Study 9627950 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac retard for 6 weeks
Number of subjects: 80
Study 8682023 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 308
Study 8682023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 2146452 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 0
Study 2146452 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 0
Study 2146452 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 0
Study 335912 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg orally twice daily for 1 week)
Number of subjects: 8
Study 335912 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (2% eyedrops three times a day)
Number of subjects: 8
Study 335912 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and Pilocarpine (combined treatment)
Number of subjects: 8
Study 335912 — intervention group
Group type: COMPARATOR
Intervention: Propranolol alone
Number of subjects: 8
Study 335912 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8
Study 31350269 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib 100 mg once daily
Number of subjects: 519
Study 31350269 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib 150 mg once daily
Number of subjects: 519
Study 31350269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 519
Study 24841333 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous monitoring of BP using the CNAP® Monitor
Number of subjects: 40
Study 24841333 — intervention group
Group type: COMPARATOR
Intervention: Intermittent oscillometric BP cuff
Number of subjects: 40
Study 23995437 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator-CRT in patients with LBBB
Number of subjects: 1483
Study 23995437 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator-CRT in patients with non-LBBB and QRS ≥160 ms
Number of subjects: 1483
Study 23995437 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator-CRT in patients with non-LBBB and QRS <160 ms
Number of subjects: 1483
Study 21304300 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinus excision and primary closure
Number of subjects: 80
Study 21304300 — intervention group
Group type: COMPARATOR
Intervention: Laying open
Number of subjects: 80
Study 18086143 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically polished (MP) acrylic resin
Number of subjects: 80
Study 18086143 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemically polished (CP) acrylic resin
Number of subjects: 80
Study 18086143 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing with MFP dentifrice
Number of subjects: 80
Study 18086143 — intervention group
Group type: COMPARATOR
Intervention: Brushing with Tartar Control dentifrice
Number of subjects: 80
Study 17051978 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid solution (A group)
Number of subjects: 74
Study 17051978 — intervention group
Group type: COMPARATOR
Intervention: Electrolyte solution (S group)
Number of subjects: 74
Study 12626906 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation
Number of subjects: 247
Study 12626906 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 247
Study 11093505 — intervention group
Group type: EXPERIMENTAL
Intervention: tThx (thoracoscopic thymectomy)
Number of subjects: 20
Study 11093505 — intervention group
Group type: COMPARATOR
Intervention: sThx (median sternotomy)
Number of subjects: 20
Study 8730075 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlated multiband masker
Number of subjects: 3
Study 8730075 — intervention group
Group type: COMPARATOR
Intervention: Single-band masker
Number of subjects: 3
Study 8730075 — intervention group
Group type: COMPARATOR
Intervention: Uncorrelated multiband masker
Number of subjects: 3
Study 1467605 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo method
Number of subjects: 300
Study 1467605 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional oil massage
Number of subjects: 300
Study 1467605 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic swaddler
Number of subjects: 300
Study 1467605 — intervention group
Group type: COMPARATOR
Intervention: Observation study
Number of subjects: 300
Study 29303025 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal 25(OH)D < 75 nmol/L during pregnancy
Number of subjects: 52
Study 29303025 — intervention group
Group type: COMPARATOR
Intervention: Maternal 25(OH)D ≥ 75 nmol/L during pregnancy
Number of subjects: 52
Study 29523173 — intervention group
Group type: EXPERIMENTAL
Intervention: Agricultural extension platform of women's groups viewing and discussing videos on nutrition-sensitive agriculture (NSA) practices, with follow-up visits.
Number of subjects: 1184
Study 29523173 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's groups viewing and discussing videos on NSA and nutrition-specific practices, with follow-up visits.
Number of subjects: 1184
Study 29523173 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's groups viewing and discussing videos on NSA and nutrition-specific practices combined with Participatory Learning and Action meetings, with follow-up visits.
Number of subjects: 1184
Study 29523173 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving basic nutrition training from government community frontline workers.
Number of subjects: 1184
Study 26874269 — intervention group
Group type: EXPERIMENTAL
Intervention: AAT-training
Number of subjects: 139
Study 26874269 — intervention group
Group type: COMPARATOR
Intervention: Sham-training
Number of subjects: 139
Study 24888230 — intervention group
Group type: EXPERIMENTAL
Intervention: Ombrabulin 35 mg/m²
Number of subjects: 176
Study 24888230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 22257576 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol‐Depot 10 mg® (test)
Number of subjects: 24
Study 22257576 — intervention group
Group type: COMPARATOR
Intervention: Progynon Depot‐10® (reference)
Number of subjects: 24
Study 20003918 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 100
Study 20003918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 17716800 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast post-and-core restorations
Number of subjects: 257
Study 17716800 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated metal post and resin composite core restorations
Number of subjects: 257
Study 17716800 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-free all-composite core restorations
Number of subjects: 257
Study 17716800 — intervention group
Group type: COMPARATOR
Intervention: All types of post-and-core restorations
Number of subjects: 257
Study 15168120 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple recall tests
Number of subjects: 0
Study 15168120 — intervention group
Group type: COMPARATOR
Intervention: Single long test of equal total duration
Number of subjects: 0
Study 15168120 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple recall tests with a brief delay (15 min)
Number of subjects: 0
Study 15168120 — intervention group
Group type: COMPARATOR
Intervention: Single test condition
Number of subjects: 0
Study 11911756 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (0.5 microg/kg per minute for 48 hours)
Number of subjects: 951
Study 11911756 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 951
Study 11911756 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 951